文献速递哮喘

哮喘与冠心病发病:观察性研究和孟德尔随机化研究

Asthma and incident coronary heart disease: an observational and Mendelian randomisation study.
PubMed 文献 · Eur Respir J · 2023-11-29

该研究采用三角验证法,先用英国医疗记录进行观察性匹配研究(n=1 522 910),再用孟德尔随机化分析(n=589 875)。观察性研究中模型1显示哮喘与冠心病风险增加6%相关(HR 1.06,95%CI 1.01-1.13),但调整就医行为后关联消失(HR 0.99,95%CI 0.94-1.05);孟德尔随机化未发现关联(OR 1.01,95%CI 0.98-1.04)。结论提示哮喘并非冠心病危险因素。

要点

  • 观察性研究中哮喘与冠心病关联在调整就医行为后消失。
  • 孟德尔随机化分析未发现哮喘与冠心病存在因果关联。
  • 既往研究可能受检测偏倚或残余混杂影响。

核心结论

  • 哮喘不是冠心病的危险因素,既往观察性关联可能源于检测偏倚或残余混杂。

研究设计与样本

  • 观察性研究:英国医疗记录按年龄、性别和全科医生诊所1:1匹配哮喘患者与普通人群,样本n=1 522 910。
  • 孟德尔随机化研究:利用UK Biobank、TAGC和CARDIoGRAM数据,使用64个哮喘单核苷酸多态性,样本n=589 875。

主要发现

  • 观察性研究模型1(调整吸烟、BMI、口服糖皮质激素、特应质和贫困)中哮喘与冠心病风险关联HR 1.06(95%CI 1.01-1.13)。
  • 观察性研究模型2(额外调整全科医生咨询频率)中关联无统计学意义,HR 0.99(95%CI 0.94-1.05)。
  • 性别修饰关联:女性HR 1.11(95%CI 1.01-1.21),男性HR 0.91(95%CI 0.84-0.98);哮喘严重程度无修饰作用。
  • 孟德尔随机化研究未发现哮喘与冠心病关联,OR 1.01(95%CI 0.98-1.04),且无性别修饰。

关键数值与推荐

  • 观察性研究模型1:哮喘与冠心病风险HR 1.06(95%CI 1.01-1.13)。
  • 观察性研究模型2:哮喘与冠心病风险HR 0.99(95%CI 0.94-1.05)。
  • 孟德尔随机化研究:哮喘与冠心病风险OR 1.01(95%CI 0.98-1.04)。

临床怎么用

  • 对于哮喘患者,冠心病风险评估应关注传统危险因素而非哮喘本身。
  • 临床中发现的哮喘与冠心病关联可能受就医行为等混杂因素影响,需谨慎解读。

局限性

  • 观察性研究可能受检测偏倚或残余混杂影响。
  • 孟德尔随机化研究结果需结合其他人群验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Observational studies suggest asthma is a risk factor for coronary heart disease (CHD) and sex modifies the risk, but they may suffer from methodological limitations. To overcome these, we applied a "triangulation approach", where different methodologies, with different potential biases, were leveraged to enhance confidence in findings. METHODS: First, we conducted an observational study using UK medical records to match asthma patients 1:1, by age, sex and general practitioner (GP) practice, to the general population. We measured the association between asthma and incident CHD (myocardial infarction: hospitalisation/death) by applying minimal sufficient adjustment: model 1, smoking, body mass index, oral corticosteroids, atopy and deprivation; model 2, additionally adjusting for healthcare behaviour (GP consultation frequency). Second, we conducted a Mendelian randomisation (MR) study using data from the UK Biobank, Trans-National Asthma Genetic Consortium (TAGC) and Coronary Artery Disease Genome-wide Replication and Meta-analysis consortium (CARDIoGRAM). Using 64 asthma single nucleotide polymorphisms, the effect of asthma on CHD was estimated with inverse variance-weighted meta-analysis and methods that adjust for pleiotropy. RESULTS: In our observational study (n=1 522 910), we found asthma was associated with 6% increased risk of CHD (model 1: HR 1.06, 95% CI 1.01-1.13); after accounting for healthcare behaviour, we found no association (model 2: HR 0.99, 95% CI 0.94-1.05). Asthma severity did not modify the association, but sex did (females: HR 1.11, 95% CI 1.01-1.21; males: HR 0.91, 95% CI 0.84-0.98). Our MR study (n=589 875) found no association between asthma and CHD (OR 1.01, 95% CI 0.98-1.04) and no modification by sex. CONCLUSIONS: Our findings suggest that asthma is not a risk factor for CHD. Previous studies may have suffered from detection bias or residual confounding.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Valencia-Hernández CA, Del Greco M F, Sundaram V, et al. Asthma and incident coronary heart disease: an observational and Mendelian randomisation study. Eur Respir J. 2023. PMID: 37945032. doi:10.1183/13993003.01788-2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。